prostate cancer
Conditions
Sponsors
The First Affiliated Hospital of Fujian Medical University
Eligibility
Sex/Gender
Male
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients with clinically diagnosed intermediate-risk prostate cancer (PSA10-20ng/ml or Gleason score 7 or ISUP grade 2/3 or TNM stage cT2b); 2. Patients who underwent PSMA PET/CT within 30 days before surgery; 3. Preoperative and postoperative clinical and pathological data are perfect; 4. Comprehensive clinical evaluation of patients who can undergo radical prostatectomy + pelvic lymph node dissection; 5. ECOG performance status score 0-2; 6. Male patients aged 18 to 75 years; 7. Main organ function: no obvious abnormality in liver, kidney, bone marrow, heart and other important organ functions; 8. All enrolled patients should take adequate barrier contraceptive measures throughout the treatment period and within 4 weeks after the end of treatment; 9. Patients must have the ability to understand and voluntarily sign the informed consent form, which must be signed prior to any trial process.
Exclusion criteria
Exclusion criteria: 1. Abnormal blood coagulation mechanism; 2. Patients with acute urinary tract infection; 3. Incomplete collection of data and information; 4. Patients with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related diseases or infections; 5. Patients who abuse alcohol or narcotic drugs, have a history of drug abuse, or have a history of mental illness; 6. Patients with claustrophobia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pathological type of tumor;Tumor volume;The cutting edge of prostate(+/-);Seminal vesicle gland, bladder neck and nerve invaded by tumor(+/-);Gleason score of tumor;Regional lymph node metastasis;Age;Body Mass Index;Patient survival situation;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactXu Ning
The First Affiliated Hospital of Fujian Medical University
Outcome results
None listed